ESR1 and breast cancer: Indeed, higher mRNA levels of ERβ2 than the ERβ1 isoform are correlated with better survival in late-onset ERα-positive BC [151], whereas high mRNA levels of ERβ1 and ERβ5 may contribute to poor survival of patients with ERα-negative BC tissue [152].